Alzheimer’s Drug Discovery Foundation Licenses SpeechDx Dataset to Lilly
The foundation’s Diagnostics Accelerator licensed its SpeechDx dataset to Eli Lilly, advancing speech-based markers for Alzheimer’s research.
Related stories
Phinia Q3 Adjusted Earnings and Revenue Rise; Shares Advance
Phinia reported higher Q3 adjusted earnings and revenue, while its shares advanced.
M impact | EQUITY | Oct 29, 2026, 02:14 PM UTC
South Electronics Reports Q3 Net Loss of 137,471 Dinars
M impact | EQUITY | Oct 29, 2026, 02:13 PM UTC
Trinity Industries Reports Lower Q3 Earnings, Higher Revenue; Maintains 2026 EPS Outlook
M impact | EQUITY | Oct 29, 2026, 02:13 PM UTC
Jinko Power Q3 Net Profit Falls 95.96% Year Over Year
M impact | EQUITY | Oct 29, 2026, 02:11 PM UTC
ACAC Investment Agrees to Sell 25% of B&S International Shares
ACAC Investment agrees to sell 25% of B&S International’s issued shares; the headline also names others without identifying them.
M impact | EQUITY | Oct 29, 2026, 02:11 PM UTC
Blue Owl Co-CEO Says Firm Owns Infrastructure Critical to Digital Economy Growth
Blue Owl co-CEO Lipschultz said the company owns physical infrastructure critical to the digital economy's growth.
M impact | EQUITY | Oct 29, 2026, 02:11 PM UTC